Gero is a data-driven biotech company. We develop new drugs against aging and other complex diseases using our AI platform. Founders: @fedichev and @geromaxim
Thanks @Nasdaq for celebrating our recent partnership with @chugai_cc to develop novel therapies for age-related diseases. 🧬🧬
Read the news: shorturl.at/JZAck
We’ve been working at the intersection of theoretical #physics, large-scale human data, and machine learning to model #aging as a complex dynamical system — specifically, the progressive loss of resilience and the accumulation of irreversible damage that drives disease.
This World Economic Forum recognition is validation that the approach we’ve taken is starting to gain broader traction. Happy to be part of the 2026 cohort.
We approach #lifespan differently at Gero. 🧬
Young people don't get Alzheimer's or cancer. Chronic disease is an aging problem. Modern medicine treats the disease after it arrives—but we can't really cure most of them.
We're taking the smarter approach: halt aging before the disease develops. By intercepting functional decline early, we extend the years that actually matter—the healthy ones. That's longevity: a dramatically longer healthspan.
The future is bright. 👏
Future Fit Asia 2026 was a success! 👏
Our R&D Director, Michael Winther, represented Gero and joined a panel to discuss current practices that go beyond #GLP-1 therapies to advance #metabolic health.
His main takeaway. ⬇️
GLP-1's impact on weight loss and metabolic fitness has spurred efforts to develop novel interventions targeting multiple pathways to promote healthy longevity. However, many nutritional and fitness approaches discussed still aren’t effectively enhancing #longevity. 📊
#Lifespan and #healthspan get the headlines. But the real goal is functional span — keeping the ability to think, learn, move, and operate, without decline.
📽️ Check out what our Co-founder and CEO, @fedichev, said about functional decline at @jpmorgan 2026.
Most of human aging is thermodynamically irreversible. This is one of the most important — and most disliked — statements in the field.
This means that the goal of extending #lifespan is not rejuvenation, but to stop the clock. ⏱️
Let me tell you how.
Think of this as the prelude to an imminent new preprint. Read more from our Co-founder and CEO, Peter Fedichev (@fedichev), on his Substack:
peterfedichev.substack.com/p… Like, share, and follow for more updates.